<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alan Dharmasaputra</style></author><author><style face="normal" font="default" size="100%">Risma</style></author><author><style face="normal" font="default" size="100%">Annisa Ullya Rasyida</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Azasterol Inhibition and Pharmacokinetic Effects on Thymidylate Synthase-Dihydrofolate Reductase from T. gondii: In Silico Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Azasterol</style></keyword><keyword><style  face="normal" font="default" size="100%">in silico</style></keyword><keyword><style  face="normal" font="default" size="100%">Toxoplasmosis</style></keyword><keyword><style  face="normal" font="default" size="100%">TS-DHFR.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">571-575</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Toxoplasmosis is a disease that causes health problems and can be found worldwide with a percentage of more than 60%, especially in developing countries such as Indonesia. Pyrimethamine-resistant strains of &lt;em&gt;T. gondii &lt;/em&gt;have been found, and it may contribute to reducing therapeutic failure in the future. Azasterol is a synthetic analog of solacongestidine, which can potentially be used as a new anti-toxoplasma drug. Resistance to the anti-toxoplasma drug, Pyrimethamine, makes Azasterol a very profitable discovery as a new anti-toxoplasma drug. This study aimed to determine the inhibitory and pharmacokinetic effects of Azasterol compounds on the development of &lt;em&gt;T. gondii &lt;/em&gt;based on &lt;em&gt;in silico&lt;/em&gt; studies. This oneshot experimental study analyzed the predicted inhibitory effect of Azasterol on Thymidylate synthasedihydrofolate reductase (TS-DHFR) from&lt;em&gt; T. gondii&lt;/em&gt; to observe the pharmacokinetic prediction and toxicity test of the Azasterol compound. Besides, this one-shot experimental study utilized the&lt;em&gt; in silico &lt;/em&gt;method. According to the results of molecular docking, Azasterol had an interaction with the TS-DHFR protein in the same binding area as the Pyrimethamine – TS-DHFR and Sulfadiazine – TS-DHFR complexes. Azasterol binding energy was higher than that of Pyrimethamine and Sulfadiazine. Azasterol had a good pharmacokinetic effect and had minimal toxic effects on the body.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><accession-num><style face="normal" font="default" size="100%">13</style></accession-num><section><style face="normal" font="default" size="100%">571</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Alan Dharmasaputra, Risma*, Annisa Ullya Rasyida&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Faculty of Medicine, Hang Tuah University, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>